MA49751A - Agents antifongiques à activité améliorée en ph acide - Google Patents
Agents antifongiques à activité améliorée en ph acideInfo
- Publication number
- MA49751A MA49751A MA049751A MA49751A MA49751A MA 49751 A MA49751 A MA 49751A MA 049751 A MA049751 A MA 049751A MA 49751 A MA49751 A MA 49751A MA 49751 A MA49751 A MA 49751A
- Authority
- MA
- Morocco
- Prior art keywords
- improved
- antifungal agents
- acid activity
- activity
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762541370P | 2017-08-04 | 2017-08-04 | |
| PCT/US2018/044619 WO2019028034A1 (fr) | 2017-08-04 | 2018-07-31 | Agents antifongiques à activité améliorée en ph acide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA49751A true MA49751A (fr) | 2020-06-10 |
| MA49751B1 MA49751B1 (fr) | 2022-12-30 |
Family
ID=63209698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA49751A MA49751B1 (fr) | 2017-08-04 | 2018-07-31 | Agents antifongiques à activité améliorée en ph acide |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US11534433B2 (fr) |
| EP (3) | EP4732902A2 (fr) |
| JP (1) | JP7214714B2 (fr) |
| KR (1) | KR102807716B1 (fr) |
| CN (2) | CN111093655A (fr) |
| AU (2) | AU2018309718B2 (fr) |
| BR (1) | BR112020002290A2 (fr) |
| CA (1) | CA3071940A1 (fr) |
| CY (1) | CY1125690T1 (fr) |
| DK (1) | DK3661503T3 (fr) |
| EA (1) | EA202090445A1 (fr) |
| ES (1) | ES2932658T3 (fr) |
| FI (1) | FI3661503T3 (fr) |
| HR (1) | HRP20221414T1 (fr) |
| HU (1) | HUE060508T2 (fr) |
| LT (1) | LT3661503T (fr) |
| MA (1) | MA49751B1 (fr) |
| MD (1) | MD3661503T2 (fr) |
| MX (1) | MX2020001399A (fr) |
| PL (1) | PL3661503T3 (fr) |
| PT (1) | PT3661503T (fr) |
| RS (1) | RS63746B1 (fr) |
| SI (1) | SI3661503T1 (fr) |
| SM (1) | SMT202200461T1 (fr) |
| TW (1) | TWI805600B (fr) |
| WO (1) | WO2019028034A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021016876A2 (pt) * | 2019-02-27 | 2021-11-03 | Scynexis Inc | Métodos para tratar e para prevenir pneumonia por pneumocystis, métodos para tratar e para prevenir pneumonia por pneumocystis jirovecii, preparação de um medicamento para tratar ou prevenir pneumonia por pneumocystis jirovecii, e, uso de um composto |
| AU2020276595B2 (en) * | 2019-05-16 | 2025-12-04 | Scynexis, Inc. | Antifungal Agents for Candida Auris Decolonization |
| WO2022140646A1 (fr) * | 2020-12-26 | 2022-06-30 | Mycovia Pharmaceuticals, Inc | Schéma posologique de l'otéséconazole |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| JP5245057B2 (ja) | 2006-04-03 | 2013-07-24 | メルク・シャープ・アンド・ドーム・コーポレーション | 抗真菌剤 |
| WO2010019204A1 (fr) | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Agents antifongiques |
| KR101686075B1 (ko) * | 2008-08-12 | 2016-12-13 | 싸이넥시스, 인크. | 항균제 |
| HRP20220544T1 (hr) | 2015-01-19 | 2022-08-05 | Scynexis, Inc. | Nove soli i polimorfi scy-078 |
| MA49889A (fr) * | 2017-04-10 | 2020-06-24 | Scynexis Inc | Agents antifongiques utilisés en association |
-
2018
- 2018-07-31 KR KR1020207005972A patent/KR102807716B1/ko active Active
- 2018-07-31 BR BR112020002290-0A patent/BR112020002290A2/pt not_active Application Discontinuation
- 2018-07-31 US US16/636,230 patent/US11534433B2/en active Active
- 2018-07-31 CA CA3071940A patent/CA3071940A1/fr active Pending
- 2018-07-31 SI SI201830810T patent/SI3661503T1/sl unknown
- 2018-07-31 LT LTEPPCT/US2018/044619T patent/LT3661503T/lt unknown
- 2018-07-31 ES ES18755632T patent/ES2932658T3/es active Active
- 2018-07-31 SM SM20220461T patent/SMT202200461T1/it unknown
- 2018-07-31 EA EA202090445A patent/EA202090445A1/ru unknown
- 2018-07-31 RS RS20221058A patent/RS63746B1/sr unknown
- 2018-07-31 HR HRP20221414TT patent/HRP20221414T1/hr unknown
- 2018-07-31 AU AU2018309718A patent/AU2018309718B2/en active Active
- 2018-07-31 DK DK18755632.9T patent/DK3661503T3/da active
- 2018-07-31 PL PL18755632.9T patent/PL3661503T3/pl unknown
- 2018-07-31 JP JP2020505869A patent/JP7214714B2/ja active Active
- 2018-07-31 EP EP25222120.5A patent/EP4732902A2/fr active Pending
- 2018-07-31 PT PT187556329T patent/PT3661503T/pt unknown
- 2018-07-31 MD MDE20200607T patent/MD3661503T2/ro not_active IP Right Cessation
- 2018-07-31 WO PCT/US2018/044619 patent/WO2019028034A1/fr not_active Ceased
- 2018-07-31 EP EP18755632.9A patent/EP3661503B1/fr not_active Revoked
- 2018-07-31 MA MA49751A patent/MA49751B1/fr unknown
- 2018-07-31 CN CN201880059398.2A patent/CN111093655A/zh active Pending
- 2018-07-31 MX MX2020001399A patent/MX2020001399A/es unknown
- 2018-07-31 CN CN202410653474.XA patent/CN118542868A/zh active Pending
- 2018-07-31 FI FIEP18755632.9T patent/FI3661503T3/fi active
- 2018-07-31 EP EP22193944.0A patent/EP4169514B1/fr active Active
- 2018-07-31 HU HUE18755632A patent/HUE060508T2/hu unknown
- 2018-08-03 TW TW107127013A patent/TWI805600B/zh active
-
2022
- 2022-11-18 US US17/990,656 patent/US20230364067A1/en not_active Abandoned
- 2022-12-06 CY CY20221100767T patent/CY1125690T1/el unknown
-
2024
- 2024-10-21 AU AU2024227501A patent/AU2024227501A1/en active Pending
- 2024-12-03 US US18/967,641 patent/US20260000656A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3408292A4 (fr) | Intéines clivées à activité d'épissage exceptionnelle | |
| MA53248A (fr) | Anticorps anti-c5 à commutation ph améliorée | |
| EP3357507A4 (fr) | Dérivé d'acide nucléique à activité immunostimulante | |
| EP3808783A4 (fr) | Nouvel acide alginique réticulé | |
| EP3621640A4 (fr) | Constructions d'anticorps d'acide nucléique optimisées | |
| EP3349582A4 (fr) | Nouvelles protéines insecticides | |
| EP3769769A4 (fr) | Acide nucléique à toxicité réduite | |
| EP3600280A4 (fr) | Formulations de chlorhydrate d'acide 1-amino-1-cyclopropanecarboxylique | |
| EP3471534A4 (fr) | Végétaux à activité de la lipase 1 réduite | |
| MA49751A (fr) | Agents antifongiques à activité améliorée en ph acide | |
| DK3833786T5 (da) | Rekombinant nucleinsyrekonstrukt | |
| EP3743035A4 (fr) | Matières acides microencapsulées | |
| EP4032551A4 (fr) | Complexe d'acide nucléique | |
| CL2018002038S1 (es) | Cultivador | |
| EP3506751A4 (fr) | Composés de thiopicolinamide à activité fongicide | |
| EP4064834C0 (fr) | Incubateur | |
| IT201700031156A1 (it) | Trattore Autonomo | |
| EP4062976C0 (fr) | Acide carbalysophosphatidique | |
| EP4000637A4 (fr) | Neuraminidase modifiée | |
| IT201600128200A1 (it) | Composti ad attivita' fungicida | |
| EP4082312A4 (fr) | Tracteur | |
| TH191181S (th) | รถแทรกเตอร์ | |
| TH191182S (th) | รถแทรกเตอร์ | |
| UA41543S (uk) | Трактор | |
| UA42067S (uk) | Трактор |